Synthesis and antibacterial activity of some novel chiral fluorophoric biscyclic macrocycles

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 18, 2007, Pages 5270-5273

  Rajakumar, Perumal ^a   Selvam, Subramaniyan ^a   Shanmugaiah, Vellaisamy ^a   Mathivanan, Narayanasamy ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Antibacterial activity; Chiral fluorophoric biscyclic macrocycles

Indexed keywords

2,2' DIHYDROXY 1,1' BINAPHTHYL; ANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; CYCLOPHANE DERIVATIVE; MACROCYCLIC COMPOUND; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; FLUORESCENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; MACROCYCLIC COMPOUNDS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SPECTROMETRY, FLUORESCENCE; STEREOISOMERISM;

EID: 34547882726     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.12.071     Document Type: Article

References (25)

1. Sakamoto M., Veno A., and Mihare H. Chem. Commun. (2000) 1741
2. Jiménez D., Máñez R.M., Sancenón F., and Soto J. Tetrahedron Lett. 43 (2002) 2823
3. Kumar S., Pramila, and Kaur S. Tetrahedron Lett. 43 (2002) 1097
4. Beletskaya I.P., Averin A.D., Bessmertnykh A.G., and Guilard R. Tetrahedron Lett. 42 (2001) 4987
5. Ossowski T., Zarzeczanska D., Zalewski L., Niedzialkowski P., Majewski R., and Szymanska A. Tetrahedron Lett. 46 (2005) 1735
6. Huang H.S., Chiu H.F., Lee A.L., Guo C.L., and Yuan C.L. Biorg. Med. Chem. 12 (2004) 6163
7. Ma M., Sun Y., and Sun G. Dyes Pigments 58 (2003) 27
8. Perry P.J., Reszka A.P., Wood A.A., Read M.A., Gowan S.M., Dosanjh H.S., Trent J.O., Jenkins T.C., Kelland L.R., and Neidle S. J. Med. Chem. 41 (1998) 4873
9. Ghosh S., and Banthia K.A. Tetrahedron Lett. 43 (2002) 6457
10. Rajakumar P., and Ganesan K. Synlett 12 (2004) 2236
11. Kampmann B., Lian Y., Klinkel K.L., Vecchi P.A., Quiring H.L., Soh C.C., and Sykes A.G. J. Org. Chem. 67 (2002) 3878
12. Li Z.B., Lin J., Zhang H.C., Sabat M., Hyacinth M., and Pu L. J. Org. Chem. 69 (2004) 6284
13. Kim K.M., Park H., Kim H.J., Chin J., and Nam W. Org. Lett. 7 (2005) 3525
14. Rajakumar P., Dhanasekaran M., Selvam S., Aravindan P.G., and Velumurugan D. J. Org. Chem. 70 (2005) 3267
15. Rajakumar P., Selvam S., and Dhanasekaran M. Tetrahedron Lett. 46 (2005) 6127
16. Rajakumar P., Sekar K., and Srinivasan K. Tetrahedron Lett. 46 (2005) 1905
17. Rajakumar P., and Srisailas M. Tetrahedron 59 (2003) 5373
18. Rajakumar P., and Srisailas M. Tetrahedron Lett. 43 (2002) 1909
19. Rajakumar P., and Srisailas M. Tetrahedron Lett. 44 (2003) 2885
20. Rajakumar P., and Srisailas M. Tetrahedron 57 (2001) 9749
21. 12: C, 80.52; H, 4.73; N, 1.88. Found: C, 80.37; H, 4.69; N, 1.78.
22. 12: C, 81.95; H, 4.95. Found: C, 81.77; H, 4.86.
23. 10: C, 84.22; H, 5.20. Found: C, 84.01; H, 5.29.
24. Antibacterial activity. The antibacterial activity of the compounds against human pathogens was evaluated by the agar diffusion method. About 1 mL of inoculum of each test pathogen was added to the molten NA medium and poured into sterile Petri plates under aseptic conditions. After solidification, a 5-mm well was made in the center of each plate using a sterile cork borer. Each compound was dissolved in 10% DMSO to get different concentrations and filter-sterilized using 0.25 μm filter paper. Each well received 50 μL solution of each compound and the plates were incubated at room temperature. Sterile DMSO (10%) was used as control. After 48 h, the appearance of inhibition zone around the well was observed.
25. Mann C.M., and Markham J.L. J. Appl. Microbiol. 84 (1998) 538